Vertaling van "risk of oral " (Frans → Nederlands) :

TERMINOLOGIE

1) oral - 2) oral (stade-) | 1) par la bouche - 2) qui se fixe sur la bouche et les lèvres
oraal | met betrekking tot de mond

produit contenant de la bétaméthasone sous forme orale
product dat betamethason in orale vorm bevat

produit contenant du bétaxolol sous forme orale
product dat betaxolol in orale vorm bevat

produit contenant du bexarotène sous forme orale
product dat bexaroteen in orale vorm bevat

produit contenant du bénorilate sous forme orale
product dat benorilaat in orale vorm bevat

produit contenant du baclofène sous forme orale
product dat baclofen in orale vorm bevat

atteinte orale par la pemphigoïde de la muqueuse
orale aantasting door slijmvlies-pemfigoïd

produit contenant de l'auranofine sous forme orale
product dat auranofine in orale vorm bevat

produit contenant seulement de l'auranofine sous forme orale
product dat enkel auranofine in orale vorm bevat

produit contenant de la bédaquiline sous forme orale
product dat bedaquiline in orale vorm bevat

IN-CONTEXT TRANSLATIONS

D’après D.M. Grabrick et al.: Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
Naar D.M. Grabrick et al.: Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.

(Khader 2003) Khader YS, Rice J, Lefante J, Abueita O. Oral contraceptive use and the risk of myocardial infarction: a metaanalysis. Contraception 2003; 68:11-7
(Khader 2003) Khader YS, Rice J, Lefante J, Abueita O. Oral contraceptive use and the risk of myocardial infarction: a meta-analysis.

(Lidegaard 2011) Lidegaard Ø, Hougaard L, Wessel Skovlund C et al. Risk of venous thromboembolism from use of oral
(Lidegaard 2011) Lidegaard Ø, Hougaard L, Wessel Skovlund C et al. Risk of venous thromboembolism from use of oral contraceptives

oral glucose tolerance test Office de la Naissance et de l'Enfance odds ratio over-the-counter papanicolou plasma protein A polymerase chain reaction Public Health Laboratory Service pregnancy-induced hypertension proton pump inhibitor positive predictive value premature rupture of membranes routine antenatal anti-D prophylaxis Royal College of Obstetricians and Gynaecologists randomised controlled trial eferences rhesus D recombinant immunoblot assay Rijksinstituut voor Ziekte- en Invaliditeitsverzekering ribonucleic acid random plasma glucose rapid plasmin reagin test relative risk reagent strip testing standard deviation single entry two step symphysis-fundal height small for gestational age Scottish Intercollegiate Guidelines Network sexueel overdraagbare aandoening Society of Obstetricians and Gynaecologists of Canada symphysis pubis dysfunction Treponema pallidum haemagglutination assay thyroïd stimulating hormone nconjugated oestriol United Kingdom United States Centers for Disease Control and Prevention US Preventive Services Task Force ultrasound scan urinary tract infection Veneral Disease Research Laboratory (test for syphilis) vaginal examination Vlaamse Organisaties van Vroedvrouwen Vlaamse Vereniging voor Obstetrie en Gynaecologie Wereldgezondheidsorganisatie World Health Organization weighted mean difference Wetenschappelijke Vereniging van Vlaamse Huisartsen
Office de la Naissance et de l'Enfance odds ratio over-the-counter papanicolou plasma protein A polymerase chain reaction Public Health Laboratory Service pregnancy-induced hypertension proton pump inhibitor positive predictive value premature rupture of membranes routine antenatal anti-D prophylaxis Royal College of Obstetricians and Gynaecologists randomised controlled trial eferences rhesus D recombinant immunoblot assay Rijksinstituut voor Ziekte- en Invaliditeitsverzekering ribonucleic acid random plasma glucose rapid plasmin reagin test relative risk reagent strip testing standard deviation single entry two step symphysis-fundal height small for gestational age Scottish Intercollegiate Guidelines Network sexueel overdraagbare aandoening Society of Obstetricians and Gynaecologists of Canada symphysis pubis dysfunction Treponema pallidum haemagglutination assay thyroïd stimulating hormone nconjugated oestriol United Kingdom United States Centers for Disease Control and

Oral contraceptive use as a risk factor for premenopausal
Oral contraceptive use as a risk factor for premenopausal breast cancer:

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone

(Fernandez 2001) Fernandez E, La Vecchia C, Balducci A et al. Oral contraceptives and colorectal cancer risk: a meta-analysis.
(FSRH POI 2009) Faculty of Sexual and Reproductive Health Care (Royal College of Obstetricians and Gynaecologists).

(Hannaford 2007) Hannaford PC, Selvaraj S, Elliott AM et al. Cancer risk among users of oral contraceptives: cohort data from
(Hannaford 2007) Hannaford PC, Selvaraj S, Elliott AM et al. Cancer risk among users of oral contraceptives: cohort data from the Royal College

(Jick 2006) Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing
(Jick 2006) Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or